methotrexate has been researched along with Granulomatosis, Lipid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fröhlich, M; Gernert, M; Heidemeier, A; Hueper, S; Portegys, J; Rasche, L; Rosenwald, A; Schmalzing, M; Strunz, PP | 1 |
| Call, TG; Go, RS; Goyal, G; Hogan, WJ; Hook, CC; Koster, MJ; Litzow, MR; Ryu, JH; Shah, MV; Tobin, WO; Vassallo, R; Wolanskyj-Spinner, AP | 1 |
| Call, TG; Go, RS; Goyal, G; Hogan, WJ; Hook, CC; Shah, MV | 1 |
| Santamarina, M; Vega, J | 1 |
| Jeon, IS; Lee, MK; Lee, SS | 1 |
5 other study(ies) available for methotrexate and Granulomatosis, Lipid
| Article | Year |
|---|---|
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib.
Topics: Arthritis; Erdheim-Chester Disease; Histiocytosis, Sinus; Humans; Interleukin 1 Receptor Antagonist Protein; Methotrexate | 2023 |
Efficacy of biological agents in the treatment of Erdheim-Chester disease.
Topics: Aged; Aged, 80 and over; Erdheim-Chester Disease; Etanercept; Female; Humans; Infliximab; Interleukin 1 Receptor Antagonist Protein; Male; Methotrexate; Middle Aged; Prednisolone; Retrospective Studies; Vemurafenib | 2018 |
Clinical and radiological responses to oral methotrexate alone or in combination with other agents in Erdheim-Chester disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Erdheim-Chester Disease; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2017 |
[Sirolimus and prednisone for the treatment of Erdheim-Chester disease with cardiac involvement: Report of one case].
Topics: Aged; Anti-Inflammatory Agents; Cardiac Tamponade; Disease-Free Survival; Erdheim-Chester Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisone; Sirolimus; Treatment Outcome | 2016 |
Chemotherapy and interferon-alpha treatment of Erdheim-Chester disease.
Topics: Adolescent; Erdheim-Chester Disease; Female; Humans; Interferon-alpha; Methotrexate; Prednisone; Vinblastine | 2010 |